Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03390296
Brief Title: OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

First Submitted : December 28, 2017
First Submitted that Met QC Criteria : December 28, 2017
First Posted : January 4, 2018

Last Update Submitted that Met QC Criteria : September 16, 2019
Last Update Posted : September 19, 2019